Nfocus Neuromedical Inc.

PALO ALTO, California, February 15, 2011 - Nfocus Neuromedical, Inc., an innovative medical device company with a focus on the next generation treatment for brain aneurysms, announced today that its Luna(TM) Aneurysm Embolization System (AES) received CE Mark for the treatment of patients with brain aneurysms.

PALO ALTO, California - Milledge brings proven experience, dynamic insights and strategic focus to neurovascular interventions developer.

PALO ALTO, California - Accomplished regulatory executive enhances Nfocus device development team.